513 Spam-Free Article(s) Found
Aug 28, 2017 - These three high-yield dividend stocks may be worth checking out right now.
Apr 12, 2018 - Names on the move ahead of the open.
Aug 14, 2017 - It's been a pretty good year for biotech, but these three stocks have tumbled. Is the pessimism overblown?
Aug 10, 2017 - Looking for income from the healthcare sector? Here's why you should check out GlaxoSmithKline, Pfizer, and CVS Health.
Dec 19, 2018 - Pfizer and GSK will combine their consumer health units and plan to spin the joint venture off.
Aug 09, 2017 - The Triangle region’s office market had an unusually high volume of new space absorption in the second quarter of 2017.
May 26, 2017 - Here are three stocks that stand a chance to double -- and then some -- over the next year or so.
Sep 13, 2017 - A Food and Drug Administration advisory panel voted unanimously Wednesday to recommend approval for GlaxoSmithKline's new drug candidate Shingrix, a vaccine for preventing shingles in adults age 50 and older.
The vote by the Vaccines and Related Biological Products Advisory Committee was 11-0 in support of the biologics license application submitted by GlaxoSmithKline last October. The committee's recommendation is nonbinding, but the FDA typically follows the advice of its advisory panels.
Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
Sep 13, 2017 - Dupixent's phase 3 trials in asthma were a success, clearing the way to an FDA filing this year in this multibillion-dollar indication.